Filing Flows › Chemed (CHE) › Q2 2026
Chemed (CHE) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 31, 2026
Chemed (CHE) reported revenue of $673M for the second quarter 2026 (Q2 2026), +9% from a year earlier and +2% from the quarter before. Operating margin was 13.2%, net earnings $67.7M (10.1% of revenue).
Chemed, Q2 2026: revenue $673M (+9% year over year), operating margin 13.2%, net earnings $67.7M, operating cash flow $84.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $673M | +2% | +9% |
| Operating profit | $89.2M | +5% | +31% |
| Net earnings | $67.7M | +2% | +29% |
| Operating cash flow | $84.8M | -4% | -39% |
| Free cash flow | $69.3M | +38% | -44% |
What changed
Revenue was $673.3M in Q2 2026, up 9% year over year and up 2% from the previous quarter. VITAS was the largest line at 66% of revenue. VITAS added $47.1M year over year (up 12%), 87% of the total change.
Operating profit was $89.2M, a 13.2% margin (up 2.2 points year over year). Of the extra revenue versus Q2 2025, 39% reached operating profit, above the 11% margin then. Total costs grew 6% against revenue growth of 9%. The fastest-growing cost line was SG&A (+15%). Net earnings were $67.7M, up 29% year over year. The effective tax rate was 25.9%.
Operating cash flow was $84.8M (down 39% year over year), 125% of net earnings. Non-cash charges added back $17.0M of depreciation and amortization. Capital expenditures of $15.5M left free cash flow of $69.3M.
Questions
What was Chemed's revenue in the second quarter 2026?
Chemed (CHE) reported revenue of $673M for the second quarter 2026 (Q2 2026), +9% from a year earlier and +2% from the quarter before.
Was Chemed profitable in the second quarter 2026?
Operating profit was $89.2M (13.2% of revenue) and net earnings $67.7M.
Source: Chemed 10-Q on SEC EDGAR.